Stocks and Investing
Stocks and Investing
Tue, December 20, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Corinne Jenkins Maintained (TERN) at Strong Buy with Increased Target to $14 on, Dec 20th, 2022
Corinne Jenkins of Goldman Sachs, Maintained "Terns Pharmaceuticals, Inc." (TERN) at Strong Buy with Increased Target from $9 to $14 on, Dec 20th, 2022.
Corinne has made no other calls on TERN in the last 4 months.
There is 1 other peer that has a rating on TERN. Out of the 1 peers that are also analyzing TERN, all agrees with Corinne's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Ed Arce of "HC Wainwright & Co." Initiated at Hold and Held Target at $6 on, Monday, September 12th, 2022
Contributing Sources